G-protein-coupled receptor kinase 2 (GRK2) inhibitors: Current trends and future perspectives

Journal of Medicinal Chemistry

Volumn 59, Issue 20, 2016, Pages 9277-9294

  Guccione, Manuela ^a   Ettari, Roberta ^a   Taliani, Sabrina ^b   Da Settimo, Federico ^b   Zappalà, Maria ^a   Grasso, Silvana ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR KINASE 2; PROTEIN SERINE THREONINE KINASE INHIBITOR; PROTEIN KINASE INHIBITOR;

CARDIOVASCULAR DISEASE; COGNITIVE DEFECT; DOWN REGULATION; EMBRYO DEVELOPMENT; HEART FAILURE; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HUMAN; INSULIN RESISTANCE; MOLECULAR WEIGHT; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYSICAL CHEMISTRY; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANIMALS; G-PROTEIN-COUPLED RECEPTOR KINASE 2; HUMANS; MOLECULAR STRUCTURE; PROTEIN KINASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84994016210     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/acs.jmedchem.5b01939     Document Type: Review

References (116)

1. Cho, S. Y.; Lee, B. H.; Jung, H.; Yun, C. S.; Ha, J. D.; Kim, H. R.; Chae, C. H.; Lee, J. H.; Seo, H. W.; Oh, K. S. Design and synthesis of novel 3-(benzo[d]oxazol-2-yl)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)-pyridin-2-amine derivatives as selective G-protein-coupled receptor kinase-2 and-5 inhibitors. Bioorg. Med. Chem. Lett. 2013, 23, 6711-6716.
2. Cheek, S.; Zhang, H.; Grishin, N. V. Sequence and structure classification of kinases. J. Mol. Biol. 2002, 320, 855-881.
3. Narayana, N.; Diller, T. C.; Koide, K.; Bunnage, M. E.; Nicolaou, K. C.; Brunton, L. L.; Xuong, N. H.; Ten Eyck, L. F.; Taylor, S. S. Crystal structure of the potent natural product inhibitor balanol in complex with the catalytic subunit of cAMP-dependent protein kinase. Biochemistry 1999, 38, 2367-2376.
4. Akamine, P.; Madhusudan; Brunton, L. L.; Ou, H. D.; Canaves, J. M.; Xuong, N. H.; Taylor, S. S. Balanol analogues probe specificity determinants and the conformational malleability of the cyclic 3',5'-adenosine monophosphate-dependent protein kinase catalytic subunit. Biochemistry 2004, 43, 85-96.
5. Gurevich, E. V.; Tesmer, J. J. G.; Mushegian, A.; Gurevich, V. V. G protein-coupled receptor kinases: more than just kinases and not only for GPCRs. Pharmacol. Ther. 2012, 133, 40-69.
6. Pearce, L. R.; Komander, D.; Alessi, D. R. The nuts and bolts of AGC protein kinases. Nat. Rev. Mol. Cell Biol. 2010, 11, 9-22.
7. Metaye, T.; Gibelin, H.; Perdrisot, R.; Kraimps, J. L. Pathophysiological roles of G-protein-coupled receptor kinases. Cell. Signalling 2005, 17, 917-928.
8. Carotenuto, A.; Cipolletta, E.; Gomez-Monterrey, I.; Sala, M.; Vernieri, E.; Limatola, A.; Bertamino, A.; Musella, S.; Sorriento, D.; Grieco, P.; Trimarco, B.; Novellino, E.; Iaccarino, G.; Campiglia, P. Design, synthesis and efficacy of novel G protein-coupled receptor kinase 2 inhibitors. Eur. J. Med. Chem. 2013, 69, 384-392.
9. Gomez-Monterrey, I.; Carotenuto, A.; Cipolletta, E.; Sala, M.; Vernieri, E.; Limatola, A.; Bertamino, A.; Musella, S.; Grieco, P.; Trimarco, B.; Novellino, E.; Iaccarino, G.; Campiglia, P. SAR study and conformational analysis of a series of novel peptide G proteincoupled receptor kinase 2 inhibitors. Biopolymers 2014, 101, 121-128.
10. Sallese, M.; Iacovelli, L.; Cumashi, A.; Capobianco, L.; Cuomo, L.; De Blasi, A. Regulation of G protein-coupled receptor kinase subtypes by calcium sensor proteins. Biochim. Biophys. Acta, Mol. Cell Res. 2000, 1498, 112-121.
11. Sallese, M.; Mariggiò, S.; D'Urbano, E.; Iacovelli, L.; De Blasi, A. Selective regulation of Gq signaling by G protein-coupled receptor kinase 2: direct interaction of kinase N terminus with activated Gαq. Mol. Pharmacol. 2000, 57, 826-831.
12. Weiss, E. R.; Raman, D.; Shirakawa, S.; Ducceschi, M. H.; Bertram, P. T.; Wong, F.; Kraft, T. W.; Osawa, S. The cloning of GRK7, a candidate cone opsin kinase, from cone-and rod-dominant mammalian retinas. Mol. Vision 1998, 8, 4-27.
13. Premont, R. T.; Macrae, A. D.; Stoffel, R. H.; Chung, N.; Pitcher, J. A.; Ambrose, C.; Inglese, J.; MacDonald, M. E.; Lefkowitz, R. J. Characterization of the G protein-coupled receptor kinase GRK4. Identification of four splice variants. J. Biol. Chem. 1996, 271, 6403-6410.
14. Sallese, M.; Mariggio, S.; Collodel, G.; Moretti, E.; Piomboni, P.; Baccetti, B.; De Blasi, A. GRK4 Molecular analysis of the four isoforms and ultrastructural localization in spermatozoa and germinal cells. J. Biol. Chem. 1997, 272, 10188-10195.
15. Felder, R. A.; Sanada, H.; Xu, J.; Yu, P. Y.; Wang, Z.; Watanabe, H.; Asico, L. D.; Wang, W.; Zheng, S.; Yamaguchi, I.; Williams, S. M.; Gainer, J.; Brown, N. J.; Hazen-Martin, D.; Wong, L. J.; Robillard, J. E.; Carey, R. M.; Eisner, G. M.; Jose, P. A. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc. Natl. Acad. Sci. U. S. A. 2002, 99, 3872-3877.
16. Brenninkmeijer, C. B.; Price, S. A.; Lopez, B. A.; Phaneuf, S. Expression of G-protein-coupled receptor kinases in pregnant term and non-pregnant human myometrium. J. Endocrinol. 1999, 162, 401-408.
17. Penela, P.; Ribas, C.; Mayor, F., Jr. Mechanisms of regulation of the expression and function of G protein-coupled receptor kinases. Cell. Signalling 2003, 15, 973-981.
18. Ribas, C.; Penela, P.; Murga, C.; Salcedo, A.; García-Hoz, C.; Jurado-Pueyo, M.; Aymerich, I.; Mayor, F., Jr. The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signalling. Biochim. Biophys. Acta, Biomembr. 2007, 1768, 913-922.
19. Daaka, Y.; Pitcher, J. A.; Richardson, M.; Stoffel, R. H.; Robishaw, J. D.; Lefkowitz, R. J. Receptor and Gβγ isoform-specific interactions with G protein-coupled receptor kinases. Proc. Natl. Acad. Sci. U. S. A. 1997, 94, 2180-2185.
20. Pitcher, J. A.; Freedman, N. J.; Lefkowitz, R. J. G proteincoupled receptor kinases. Annu. Rev. Biochem. 1998, 67, 653-692.
21. Shenoy, S. K.; Lefkowitz, R. J. Multifaceted roles of β-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem. J. 2003, 375, 503-515.
22. Ruiz-Gomez, A.; Mayor, F., Jr. β-Adrenergic receptor kinase (GRK2) colocalizes with β-adrenergic receptors during agonistinduced receptor internalization. J. Biol. Chem. 1997, 272, 9601-9604.
23. Freedman, N. J.; Kim, L. K.; Murray, J. P.; Exum, S. T.; Brian, L.; Wu, J.-H.; Peppel, K. Phosphorylation of the platelet-derived growth factor receptor-β and epidermal growth factor receptor by G protein-coupled receptor kinase-2: mechanisms for selectivity of desensitization. J. Biol. Chem. 2002, 277, 48261-48269.
24. Hildreth, K. L.; Wu, J. H.; Barak, L. S.; Exum, S. T.; Kim, L. K.; Peppel, K.; Freedman, N. J. Phosphorylation of the Platelet-derived Growth Factor Receptor-β by G Protein-coupled Receptor Kinase-2 Reduces Receptor Signaling and Interaction with the Na+/H+ Exchanger Regulatory Factor. J. Biol. Chem. 2004, 279, 41775-41782.
25. Chen, W.; Ren, X.-R.; Nelson, C. D.; Barak, L. S.; Chen, J. K.; Beachy, P. A.; de Sauvage, F.; Lefkowitz, R. J. Activity-dependent internalization of smoothened mediated by β-arrestin 2 and GRK2. Science 2004, 306, 2257-2260.
26. Chen, Y.; Sasai, N.; Ma, G.; Yue, T.; Jia, J.; Briscoe, J.; Jiang, J. Hedgehog, S. Dependent phosphorylation by CK1a and GRK2 is required for ciliary accumulation and activation of smoothened. PLoS Biol. 2011, 9, e1001083.
27. Carman, C. V.; Som, T.; Kim, C. M.; Benovic, J. L. Binding and phosphorylation of tubulin by G protein-coupled receptor kinases. J. Biol. Chem. 1998, 273, 20308-20316.
28. Cant, S. H.; Pitcher, J. A. G protein-coupled receptor kinase 2-mediated phosphorylation of ezrin is required for G protein-coupled receptor-dependent reorganization of the actin cytoskeleton. Mol. Biol. Cell 2005, 16, 3088-3099.
29. Kahsai, A. W.; Zhu, S.; Fenteany, G. G protein-coupled receptor kinase 2 activates radixin, regulating membrane protrusion and motility in epithelial cells. Biochim. Biophys. Acta, Mol. Cell Res. 2010, 1803, 300-310.
30. Usui, I.; Imamura, T.; Babendure, J. L.; Satoh, H.; Lu, J. C.; Hupfeld, C. J.; Olefsky, J. M. G protein-coupled receptor kinase 2 mediates endothelin-1-induced insulin resistance via the inhibition of both Galphaq/11 and insulin receptor substrate-1 pathways in 3T3-L1 adipocytes. Mol. Endocrinol. 2005, 19, 2760-2768.
31. Fusco, A.; Santulli, G.; Sorriento, D.; Cipolletta, E.; Garbi, C.; Dorn, G. W., 2nd; Trimarco, B.; Feliciello, A.; Iaccarino, G. Mitochondrial localization unveils a novel role for GRK2 in organelle biogenesis. Cell. Signalling 2012, 24, 468-475.
32. Ho, J.; Cocolakis, E.; Dumas, V. M.; Posner, B. I.; Laporte, S. A.; Lebrun, J.-J. The G protein-coupled receptor kinase-2 is a TGFβ-inducible antagonist of TGFβ signal transduction. EMBO J. 2005, 24, 3247-3258.
33. Carman, C. V.; Parent, J. L.; Day, P. W.; Pronin, A. N.; Sternweis, P. M.; Wedegaertner, P. B.; Gilman, A. G.; Benovic, J. L.; Kozasa, T. Selective regulation of Galpha(q/11) by an RGS domain in the G protein-coupled receptor kinase, GRK2. J. Biol. Chem. 1999, 274, 34483-34492.
34. Hollinger, S.; Hepler, J. R. Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacol. Rev. 2002, 54, 527-559.
35. Pitcher, J. A.; Inglese, J.; Higgins, J. B.; Arriza, J. L.; Casey, P. J.; Kim, C.; Benovic, J. L.; Kwatra, M. M.; Caron, M. G.; Lefkowitz, R. J. Role of beta gamma subunits of G proteins in targeting the betaadrenergic receptor kinase to membrane-bound receptors. Science 1992, 257, 1264-1267.
36. Haga, K.; Haga, T. Activation by G protein beta gamma subunits of agonist-or light-dependent phosphorylation of muscarinic acetylcholine receptors and rhodopsin. J. Biol. Chem. 1992, 267, 2222-2227.
37. Koch, W. J.; Inglese, J.; Stone, W. C.; Lefkowitz, R. J. The binding site for the βγ subunits of heterotrimeric G proteins on the β-adrenergic receptor kinase. J. Biol. Chem. 1993, 268, 8256-8260.
38. DebBurman, S. K.; Ptasienski, J.; Boetticher, E.; Lomasney, J. W.; Benovic, J. L.; Hosey, M. M. Lipid-mediated Regulation of G Protein-coupled Receptor Kinases 2 and 3. J. Biol. Chem. 1995, 270, 5742-5747.
39. Jaber, M.; Koch, W. J.; Rockman, H.; Smith, B.; Bond, R. A.; Sulik, K. K.; Ross, J., Jr.; Lefkowitz, R. J.; Caron, M. G.; Giros, B. Essential role of β-adrenergic receptor kinase 1 in cardiac development and function. Proc. Natl. Acad. Sci. U. S. A. 1996, 93, 12974-12979.
40. Lymperopoulos, A. GRK2 and β-arrestins in cardiovascular disease: Something old, something new. Am. J. Cardiovasc. Dis. 2011, 1, 126-137.
41. Vroon, A.; Heijnen, C. J.; Kavelaars, A. GRKs and arrestins: regulators of migration and inflammation. J. Leukocyte Biol. 2006, 80, 1214-1221.
42. Penela, P.; Ribas, C.; Aymerich, I.; Mayor, F., Jr. New roles of G protein-coupled receptor kinase 2 (GRK2) in cell migration. Cell Adhes. Migr. 2009, 3, 19-23.
43. Penela, P.; Murga, C.; Ribas, C.; Lafarga, V.; Mayor, F., Jr. The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets. Br. J. Pharmacol. 2010, 160, 821-832.
44. Rockman, H. A.; Choi, D. J.; Akhter, S. A.; Jaber, M.; Giros, B.; Lefkowitz, R. J.; Caron, M. G.; Koch, W. J. Control of myocardial contractile function by the level of β-adrenergic receptor kinase 1 in gene-targeted mice. J. Biol. Chem. 1998, 273, 18180-18184.
45. Matkovich, S. J.; Diwan, A.; Klanke, J. L.; Hammer, D. J.; Marreez, Y.; Odley, A. M.; Brunskill, E. W.; Koch, W. J.; Schwartz, R. J.; Dorn, G. W., 2nd. Cardiac-specific ablation of G-protein receptor kinase 2 redefines its roles in heart development and beta-adrenergic signaling. Circ. Res. 2006, 99, 996-1003.
46. Rivas, V.; Carmona, R.; Muñoz-Chápuli, R.; Mendiola, M.; Nogués, L.; Reglero, C.; Miguel-Martín, M.; García-Escudero, R.; Dorn, G. W., 2nd; Hardisson, D.; Mayor, F., Jr. Developmental and tumoral vascularization is regulated by G protein-coupled receptor kinase 2. J. Clin. Invest. 2013, 123, 4714-4730.
47. Woodall, M. C.; Ciccarelli, M.; Woodall, B. P.; Koch, W. J. G protein-coupled receptor kinase 2: A link between myocardial contractile function and cardiac metabolism. Circ. Res. 2014, 114, 1661-1670.
48. Koch, W. J.; Rockman, H. A.; Samama, P.; Hamilton, R. A.; Bond, R. A.; Milano, C. A.; Lefkowitz, R. J. Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. Science 1995, 268, 1350-1353.
49. Anderson, K. M.; Eckhart, A. D.; Willette, R. N.; Koch, W. J. The myocardial beta-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats. Hypertension 1999, 33, 402-407.
50. Ungerer, M.; Bohm, M.; Elce, J. S.; Erdmann, E.; Lohse, M. J. Altered expression of beta-adrenergic receptor kinase and beta1-adrenergic receptors in the failing human heart. Circulation 1993, 87, 454-463.
51. Ungerer, M.; Parruti, G.; Bohm, M.; Puzicha, M.; De Blasi, A.; Erdmann, E.; Lohse, M. J. Expression of β-arrestin and β-adrenoceptor kinases in the failing human heart. Circ. Res. 1994, 74, 206-213.
52. Rockman, H. A.; Chien, K. R.; Choi, D. J.; Iaccarino, G.; Hunter, J. J.; Ross, J., Jr.; Lefkowitz, R. J.; Koch, W. J. Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc. Natl. Acad. Sci. U. S. A. 1998, 95, 7000-7005.
53. White, D. C.; Hata, J. A.; Shah, A. S.; Glower, D. D.; Lefkowitz, R. J.; Koch, W. J. Preservation of myocardial b-adrenergic receptor signaling delays the development of heart failure after myocardial infarction. Proc. Natl. Acad. Sci. U. S. A. 2000, 97, 5428-5433.
54. Penela, P.; Murga, C.; Ribas, C.; Tutor, A. S.; Peregrín, S.; Mayor, F., Jr. Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease. Cardiovasc. Res. 2006, 69, 46-56.
55. Lymperopoulos, A.; Rengo, G.; Funakoshi, H.; Eckhart, A. D.; Koch, W. J. Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure. Nat. Med. 2007, 13, 315-323.
56. Dorn, G. W., 2nd. GRK mythology: G-protein receptor kinases in cardiovascular disease. J. Mol. Med. 2009, 87, 455-463.
57. Ungerer, M.; Kessebohm, K.; Kronsbein, K.; Lohse, M. J.; Richardt, G. Activation of beta-adrenergic receptor kinase during myocardial ischemia. Circ. Res. 1996, 79, 455-460.
58. Ciccarelli, M.; Chuprun, J. K.; Rengo, G.; Gao, E.; Wei, Z.; Peroutka, R. J.; Gold, J. I.; Gumpert, A.; Chen, M.; Otis, N. J.; Dorn, G. W., 2nd; Trimarco, B.; Iaccarino, G.; Koch, W. J. G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia. Circulation 2011, 123, 1953-1962.
59. Usui, I.; Imamura, T.; Satoh, H.; Huang, J.; Babendure, J. L.; Hupfeld, C. J.; Olefsky, J. M. GRK2 is an endogenous protein inhibitor of the insulin signaling pathway for glucose transport stimulation. EMBO J. 2004, 23, 2821-2829.
60. Imamura, T.; Vollenweider, P.; Egawa, K.; Clodi, M.; Ishibashi, K.; Nakashima, N.; Ugi, S.; Adams, J. W.; Brown, J. H.; Olefsky, J. M. G alpha-q/11 protein plays a key role in insulin-induced glucose transport in 3T3-L1 adipocytes. Mol. Cell. Biol. 1999, 19, 6765-6774.
61. Cipolletta, E.; Campanile, A.; Santulli, G.; Sanzari, E.; Leosco, D.; Campiglia, P.; Trimarco, B.; Iaccarino, G. The G protein coupled receptor kinase 2 plays an essential role in beta-adrenergic receptorinduced insulin resistance. Cardiovasc. Res. 2009, 84, 407-415.
62. Salcedo, A.; Mayor, F., Jr.; Penela, P. Mdm2 is involved in the ubiquitination and degradation of G-protein-coupled receptor kinase 2. EMBO J. 2006, 25, 4752-4762.
63. Garcia-Guerra, L.; Nieto-Vazquez, I.; Vila-Bedmar, R.; Jurado-Pueyo, M.; Zalba, G.; Díez, J.; Murga, C.; Fernández-Veledo, S.; Mayor, F., Jr.; Lorenzo, M. G protein-coupled receptor kinase 2 plays a relevant role in insulin resistance and obesity. Diabetes 2010, 59, 2407-2417.
64. Vila-Bedmar, R.; Cruces-Sande, M.; Lucas, E.; Willemen, H. L.; Heijnen, C. J.; Kavelaars, A.; Mayor, F., Jr.; Murga, C. Reversal of dietinduced obesity and insulin resistance by inducible genetic ablation of GRK2. Sci. Signaling 2015, 8, ra73.
65. Penela, P.; Rivas, V.; Salcedo, A.; Mayor, F., Jr. G proteincoupled receptor kinase 2 (GRK2) modulation and cell cycle progression. Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 1118-1123.
66. Pitcher, J. A.; Tesmer, J. J.; Freeman, J. L.; Capel, W. D.; Stone, W. C.; Lefkowitz, R. J. Feedback inhibition of G protein-coupled receptor kinase 2 (GRK2) activity by extracellular signal-regulated kinases. J. Biol. Chem. 1999, 274, 34531-34534.
67. Metaye, T.; Levillain, P.; Kraimps, J. L.; Perdrisot, R. Immunohistochemical detection, regulation and antiproliferative function of G-protein-coupled receptor kinase 2 in thyroid carcinomas. J. Endocrinol. 2008, 198, 101-110.
68. Wei, Z.; Hurtt, R.; Ciccarelli, M.; Koch, W. J.; Doria, C. Growth Inhibition of Human Hepatocellular Carcinoma Cells by Overexpression of G-Protein-Coupled Receptor Kinase 2. J. Cell. Physiol. 2012, 227, 2371-2377.
69. Hu, M.; Wang, C.; Li, W.; Lu, W.; Bai, Z.; Qin, D.; Yan, Q.; Zhu, J.; Krueger, B. J.; Renne, R.; Gao, S.-J.; Lu, C. A KSHV microRNA Directly Targets G Protein-Coupled Receptor Kinase 2 to Promote the Migration and Invasion of Endothelial Cells by Inducing CXCR2 and Activating AKT Signaling. PLoS Pathog. 2015, 11, e1005171.
70. Fu, X.; Koller, S.; Abd Alla, J.; Quitterer, U. Inhibition of Gprotein-coupled Receptor Kinase 2 (GRK2) Triggers the Growthpromoting Mitogen-activated Protein Kinase (MAPK) Pathway. J. Biol. Chem. 2013, 288, 7738-7755.
71. Vroon, A.; Heijnen, C. J.; Lombardi, M. S.; Cobelens, P. M.; Mayor, F., Jr.; Caron, M. G.; Kavelaars, A. Reduced GRK2 level in T cells potentiates chemotaxis and signaling in response to CCL4. J. Leukocyte Biol. 2004, 75, 901-909.
72. Lombardi, M. S.; Kavelaars, A.; Schedlowski, M.; Bijlsma, J. W.; Okihara, K. L.; Van de Pol, M. Decreased expression and activity of Gprotein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis. FASEB J. 1999, 13, 715-725.
73. Vroon, A.; Kavelaars, A.; Limmroth, V.; Lombardi, M. S.; Goebel, M. U.; Van Dam, A. M.; Caron, M. G.; Schedlowski, M.; Heijnen, C. J. G protein-coupled receptor kinase 2 in multiple sclerosis and experimental autoimmune encephalomyelitis. J. Immunol. 2005, 174, 4400-4406.
74. Vroon, A.; Lombardi, M. S.; Kavelaars, A.; Heijnen, C. J. Changes in the G protein-coupled receptor desensitization machinery during relapsing-progressive experimental allergic encephalomyelitis. J. Neuroimmunol. 2003, 137, 79-86.
75. Giorelli, M.; Livrea, P.; Trojano, M. Post-receptorial mechanisms underlie functional disregulation of beta2-adrenergic receptors in lymphocytes from Multiple Sclerosis patients. J. Neuroimmunol. 2004, 155, 143-149.
76. Arraes, S. M. A.; Freitas, M. S.; da Silva, S. V.; de Paula Neto, H. A.; Alves-Filho, J. C.; Martins, M. A. Impaired neutrophil chemotaxis in sepsis associates with GRK expression and inhibition of actin assembly and tyrosine phosphorylation. Blood 2006, 108, 2906-2913.
77. Obrenovich, M. E.; Smith, M. A.; Siedlak, S. L.; Chen, S. G.; De La Torre, J. C.; Perry, G.; Aliev, G. Overexpression of GRK2 in Alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions. Neurotoxic. Res. 2006, 10, 43-56.
78. Leosco, D.; Fortunato, F.; Rengo, G.; Iaccarino, G.; Sanzari, E.; Golino, L. Lymphocyte G-protein-coupled receptor kinase-2 is upregulated in patients with Alzheimer's disease. Neurosci. Lett. 2007, 415, 279-282.
79. Elliott, J. M. Peripheral markers in anxiety and depression. Mol. Aspects Med. 1992, 13, 173-190.
80. Camacho, A.; Dimsdale, J. E. Platelets and psychiatry: lessons learned from old and new studies. Psychosom. Med. 2000, 62, 326-336.
81. García-Sevilla, J. A.; Escribá, P. V.; Ozaita, A.; La Harpe, R.; Walzer, C.; Eytan, A. Up-regulation of immunolabeled α2Aadrenoceptors, Gi coupling proteins, and regulatory receptor kinases in the prefrontal cortex of depressed suicides. J. Neurochem. 1999, 72, 282-291.
82. Grange-Midroit, M.; Garcia-Sevilla, J. A.; Ferrer-Alcon, M.; La Harpe, R.; Huguelet, P.; Guimon, J. Regulation of GRK 2 and 6, betaarrestin-2 and associated proteins in the prefrontal cortex of drug-free and antidepressant drug-treated subjects with major depression. Mol. Brain Res. 2003, 111, 31-41.
83. Evron, T.; Daigle, T. L.; Caron, M. G. GRK2: multiple roles beyond G protein-coupled receptor desensitization. Trends Pharmacol. Sci. 2012, 33, 154-164.
84. Tesmer, V. M.; Kawano, T.; Shankaranarayanan, A.; Kozasa, T.; Tesmer, J. J. Snapshot of activated G proteins at the membrane: The Gαq-GRK2-Gβγ complex. Science 2005, 310, 1686-1690.
85. Lodowski, D. T.; Pitcher, J. A.; Capel, W. D.; Lefkowitz, R. J.; Tesmer, J. J. Keeping G proteins at bay: A complex between G proteincoupled receptor kinase 2 and Gβγ. Science 2003, 300, 1256-1262.
86. Lodowski, D. T.; Barnhill, J. F.; Pyskadlo, R. M.; Ghirlando, R.; Sterne-Marr, R.; Tesmer, J. J. The role of Gβγ and domain interfaces in the activation of G protein-coupled receptor kinase 2. Biochemistry 2005, 44, 6958-6970.
87. Tesmer, J. J. G.; Tesmer, M. V.; Lodowski, T. D.; Steinhagen, H.; Huber, J. Structure of human G protein-coupled receptor kinase 2 in complex with the kinase inhibitor balanol. J. Med. Chem. 2010, 53, 1867-1870.
88. Thal, D. M.; Yeow, R. Y.; Schoenau, C.; Huber, J.; Tesmer, J. J. Molecular mechanism of selectivity among G protein-coupled receptor kinase 2 inhibitors. Mol. Pharmacol. 2011, 80, 294-303.
89. Tesmer, V. M.; Lennarz, S.; Mayer, G.; Tesmer, J. J. G. Molecular mechanism for inhibition of G protein-coupled receptor kinase 2 by a selective RNA aptamer. Structure 2012, 20, 1300-1309.
90. Thal, D. M.; Homan, K. T.; Chen, J.; Wu, E. K.; Hinkle, P. M.; Huang, Z. M.; Chuprun, J. K.; Song, J.; Gao, E.; Cheung, J. Y.; Sklar, L. A.; Koch, W. J.; Tesmer, J. J. Paroxetine is a direct inhibitor of G protein-coupled receptor kinase 2 and increases myocardial contractility. ACS Chem. Biol. 2012, 7, 1830-1839.
91. Homan, K. T.; Wu, E. K.; Wilson, M. W.; Singh, P.; Larsen, S. D.; Tesmer, J. J. Structural and functional analysis of G proteincoupled receptor kinase inhibition by paroxetine and a rationally designed analog. Mol. Pharmacol. 2014, 85, 237-248.
92. Homan, K. T.; Larimore, K. M.; Elkins, J. M.; Szklarz, M.; Knapp, S.; Tesmer, J. J. G. Identification and structure-function analysis of subfamily selective G protein-coupled receptor kinase inhibitors. ACS Chem. Biol. 2015, 10, 310-319.
93. Dhami, G. K.; Anborgh, P. H.; Dale, L. B.; Sterne-Marr, R.; Ferguson, S. S. Phosphorylation-independent regulation of metabotropic glutamate receptor signaling by G protein-coupled receptor kinase 2. J. Biol. Chem. 2002, 277, 25266-25272.
94. Benovic, J. L.; Stone, W. C.; Caron, M. G.; Lefkowitz, R. J. Inhibition of the β-adrenergic receptor kinase by polyanions. J. Biol. Chem. 1989, 264, 6707-6710.
95. Hathaway, G. M.; Lubben, T. H.; Traugh, J. A. Inhibition of casein kinase II by heparin. J. Biol. Chem. 1980, 255, 8038-8041.
96. Kishimoto, A.; Brown, M. S.; Slaughter, C. A.; Goldstein, J. L. Phosphorylation of serine 833 in cytoplasmic domain of low density lipoprotein receptor by a high molecular weight enzyme resembling casein kinase II. J. Biol. Chem. 1987, 262, 1344-1351.
97. Setyawan, J.; Koide, K.; Diller, T. C.; Bunnage, M. E.; Taylor, S. S.; Nicolaou, K. C.; Brunton, L. L. Inhibition of protein kinases by balanol: specificity within the serine/threonine protein kinase subfamily. Mol. Pharmacol. 1999, 56, 370-376.
98. Homan, K. T.; Tesmer, J. J. G. Molecular basis for small molecule inhibition of G protein-coupled receptor kinases. ACS Chem. Biol. 2015, 10, 246-256.
99. Ikeda, S.; Keneko, M.; Fujiwara, S.Cardiotonic agent comprising GRK inhibitor. WO2007034846, March 29, 2007; Takeda Pharmaceutical Company Ltd.
100. Lowe, J. D.; Sanderson, H. S.; Cooke, A. E.; Ostovar, M.; Tsisanova, E.; Withey, S. L.; Chavkin, C.; Husbands, S. M.; Kelly, E.; Henderson, G.; Bailey, C. P. Role of G Protein-Coupled Receptor Kinases 2 and 3 in μ-Opioid Receptor Desensitization and Internalization. Mol. Pharmacol. 2015, 88, 347-356.
101. Wilson, D. S.; Szostak, J. W. In vitro selection of functional nucleic acids. Annu. Rev. Biochem. 1999, 68, 611-647.
102. Hartig, J. S.; Najafi-Shoushtari, S. H.; Grune, I.; Yan, A.; Ellington, A. D.; Famulok, M. Protein-dependent ribozymes report molecular interactions in real time. Nat. Biotechnol. 2002, 20, 717-722.
103. Hafner, M.; Schmitz, A.; Grune, I.; Srivatsan, S. G.; Paul, B.; Kolanus, W.; Quast, T.; Kremmer, E.; Bauer, I.; Famulok, M. Inhibition of cytohesins by SecinH3 leads to hepatic insulin resistance. Nature 2006, 444, 941-944.
104. Mayer, G.; Wulffen, B.; Huber, C.; Brockmann, J.; Flicke, B.; Neumann, L.; Hafenbradl, D.; Klebl, B. M.; Lohse, M. J.; Krasel, C.; Blind, M. An RNA molecule that specifically inhibits G proteincoupled receptor kinase 2 in vitro. RNA 2008, 14, 524-534.
105. Schumacher, S. M.; Gao, E.; Zhu, W.; Chen, X.; Chuprun, J. K.; Feldman, A. M.; Tesmer, J. J.; Koch, W. J. Paroxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarction. Sci. Transl. Med. 2015, 7, 277ra31.
106. Tang, J.; Dong, J.; Yang, L.; Gao, L.; Zheng, J. Paroxetine alleviates rat limb post-ischemia induced allodynia through GRK2 upregulation in superior cervical ganglia. Int. J. Clin. Exp. Med. 2015, 8, 2065-2076.
107. Harding, V. B.; Jones, L. R.; Lefkowitz, R. J.; Koch, W. J.; Rockman, H. A. Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure. Proc. Natl. Acad. Sci. U. S. A. 2001, 98, 5809-5814.
108. Benovic, J. L.; Onorato, J.; Lohse, M. J.; Dohlman, D. G.; Staniszewski, C.; Caron, M. G.; Lefkowitz, R. J. Synthetic peptides of the hamster β2-adrenoceptor as substrates and inhibitors of the β-adrenoceptor kinase. Br. J. Clin. Pharmacol. 1990, 30, 3S-12S.
109. Winstel, R.; Ihlenfeldt, H. G.; Jung, G.; Krasel, C.; Lohse, M. J. Peptide inhibitors of G protein-coupled receptor kinases. Biochem. Pharmacol. 2005, 70, 1001-1008.
110. Abdalla, S.; Fu, X.; Elzahwy, S. S.; Klaetschke, K.; Streichert, T.; Quitterer, U. Up-regulation of the cardiac lipid metabolism at the onset of heart failure. Cardiovasc. Hematol. Agents Med. Chem. 2011, 9, 190-206.
111. Abd Alla, J.; Graemer, M.; Fu, X.; Quitterer, U. Inhibition of Gprotein-coupled Receptor Kinase 2 Prevents the Dysfunctional Cardiac Substrate Metabolism in Fatty Acid Synthase Transgenic Mice. J. Biol. Chem. 2016, 291, 2583-2600.
112. Kim, J. E.; Ahn, M. W.; Baek, S. H.; Lee, I. K.; Kim, Y. W.; Kim, J. Y.; Dan, J. M.; Park, S. Y. AMPK activator, AICAR, inhibits palmitate-induced apoptosis in osteoblast. Bone 2008, 43, 394-404.
113. Anis, Y.; Leshem, O.; Reuveni, H.; Wexler, I.; Ben Sasson, R.; Yahalom, B.; Laster, M.; Raz, I.; Ben Sasson, S.; Shafrir, E.; Ziv, E. Antidiabetic effect of novel modulating peptides of G-protein-coupled kinase in experimental models of diabetes. Diabetologia 2004, 47, 1232-1244.
114. Tseng, C. C.; Zhang, X. Y. Role of G protein-coupled receptor kinases in glucose-dependent insulinotropic polypeptide receptor signaling. Endocrinology 2000, 141, 947-952.
115. Sun, H.; Zu, Y. A Highlight of Recent Advances in Aptamer Technology and Its Application. Molecules 2015, 20, 11959-11980.
116. Wang, R. E.; Wu, H.; Niu, Y.; Cai, J. Improving the stability of aptamers by chemical modification. Curr. Med. Chem. 2011, 18, 4126-4138.